72.2%), although this difference did not reach statistical significance ( Figure 1 E).
← all excerpts
The Assessment of Multidimensional Clinical, Biological and Patient-Reported Outcomes to Evaluate the Efficacy of Add-On <i>Lactobacillus rhamnosus</i> GG Supplementation in Mild Ulcerative Colitis: A Randomized Pilot Trial.
1
—
—